UPDATE: Jefferies Downgrades Esperion Therapeutics (ESPR) to Hold
Tweet Send to a Friend
(Updated - February 12, 2021 7:58 AM EST)
Jefferies analyst Michael Yee downgraded Esperion Therapeutics (NASDAQ: ESPR) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Michael Yee downgraded Esperion Therapeutics (NASDAQ: ESPR) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
